Bifogade filer
Kurs
-6,92%
Likviditet
155 MSEK
Kalender
Tid* | ||
2026-02-02 | 08:00 | Bokslutskommuniké 2025 |
2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-07-15 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-05-08 | N/A | Årsstämma |
2025-04-25 | 08:00 | Kvartalsrapport 2025-Q1 |
2025-02-05 | 08:00 | Bokslutskommuniké 2024 |
2024-10-23 | - | Kvartalsrapport 2024-Q3 |
2024-07-15 | - | Kvartalsrapport 2024-Q2 |
2024-05-10 | - | X-dag ordinarie utdelning ALIF B 0.50 SEK |
2024-05-08 | - | Årsstämma |
2024-04-24 | - | Kvartalsrapport 2024-Q1 |
2024-02-02 | - | Bokslutskommuniké 2023 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-07-14 | - | Kvartalsrapport 2023-Q2 |
2023-05-05 | - | X-dag ordinarie utdelning ALIF B 1.20 SEK |
2023-05-04 | - | Årsstämma |
2023-04-26 | - | Kvartalsrapport 2023-Q1 |
2023-02-02 | - | Bokslutskommuniké 2022 |
2022-10-27 | - | Kvartalsrapport 2022-Q3 |
2022-07-15 | - | Kvartalsrapport 2022-Q2 |
2022-05-06 | - | X-dag ordinarie utdelning ALIF B 2.00 SEK |
2022-05-05 | - | Årsstämma |
2022-04-28 | - | Kvartalsrapport 2022-Q1 |
2022-02-04 | - | Bokslutskommuniké 2021 |
2021-10-22 | - | Kvartalsrapport 2021-Q3 |
2021-07-15 | - | Kvartalsrapport 2021-Q2 |
2021-05-06 | - | X-dag ordinarie utdelning ALIF B 1.50 SEK |
2021-05-05 | - | Årsstämma |
2021-04-28 | - | Kvartalsrapport 2021-Q1 |
2021-02-03 | - | Bokslutskommuniké 2020 |
2020-11-20 | - | X-dag ordinarie utdelning ALIF B 0.50 SEK |
2020-11-20 | - | X-dag bonusutdelning ALIF B 0.5 |
2020-11-19 | - | Extra Bolagsstämma 2020 |
2020-10-22 | - | Kvartalsrapport 2020-Q3 |
2020-07-17 | - | Kvartalsrapport 2020-Q2 |
2020-05-27 | - | Split ALIF B 1:4 |
2020-05-08 | - | X-dag ordinarie utdelning ALIF B 2.40 SEK |
2020-05-07 | - | Årsstämma |
2020-04-28 | - | Kvartalsrapport 2020-Q1 |
2020-02-06 | - | Bokslutskommuniké 2019 |
2019-11-07 | - | Kvartalsrapport 2019-Q3 |
2019-07-12 | - | Kvartalsrapport 2019-Q2 |
2019-05-10 | - | X-dag ordinarie utdelning ALIF B 2.20 SEK |
2019-05-09 | - | Årsstämma |
2019-05-09 | - | Kvartalsrapport 2019-Q1 |
2019-02-12 | - | Bokslutskommuniké 2018 |
2018-12-20 | - | Extra Bolagsstämma 2018 |
2018-11-07 | - | Kvartalsrapport 2018-Q3 |
2018-07-13 | - | Kvartalsrapport 2018-Q2 |
2018-06-01 | - | X-dag ordinarie utdelning ALIF B 2.20 SEK |
2018-05-31 | - | Årsstämma |
2018-04-27 | - | Kvartalsrapport 2018-Q1 |
2018-02-13 | - | Bokslutskommuniké 2017 |
2017-10-26 | - | Kvartalsrapport 2017-Q3 |
2017-07-17 | - | Kvartalsrapport 2017-Q2 |
2017-05-30 | - | X-dag ordinarie utdelning ALIF B 1.50 SEK |
2017-05-29 | - | Årsstämma |
2017-04-28 | - | Kvartalsrapport 2017-Q1 |
2017-02-16 | - | Bokslutskommuniké 2016 |
2016-10-27 | - | Kvartalsrapport 2016-Q3 |
2016-09-02 | - | X-dag ordinarie utdelning ALIF B 0.00 SEK |
2016-09-01 | - | Årsstämma |
2016-07-15 | - | Kvartalsrapport 2016-Q2 |
Beskrivning
Land | Sverige |
---|---|
Lista | Large Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
AddLife has today repurchased own shares of 110,000 Class B shares at a price of SEK 104.05 per share. The purchase has been made via Nasdaq Stockholm at the price interval prevailing.
The repurchase is carried out in accordance with the Annual General Meeting's authorization to the Board to acquire shares in the Company. The purpose of the repurchase is to cover the Company’s obligations under previously resolved incentive programs and to make possible future acquisitions of companies and businesses with payment in the form of shares in the Company.
AddLife AB holds after the repurchase totally 748,089 class B shares in treasury, equivalent to 0.6 percent of the total number of shares outstanding, and 0.5 percent of the votes. The total number of shares outstanding in AddLife AB, including shares held in treasury, is 122,450,250, where of 4,615,136 are Class A shares and 117,835,114 are Class B shares.
Stockholm, October 28, 2022
AddLife AB (publ)
For more information, contact;
Fredrik Dalborg, VD, fredrik.dalborg@add.life, +46 70 516 09 01
Christina Rubenhag, CFO, christina.rubenhag@add.life, +46 70 546 72 22
www.add.life
AddLife is an independent player in the Life Science industry that offers high-quality products, services and advice to both the private and public sectors, mainly in the Nordic region and rest of Europe. AddLife has about 2,200 employees in some 85 operating subsidiaries. The Group currently has net sales of approximately SEK 9 billion. AddLife shares are listed on Nasdaq Stockholm.
The information was submitted for publication at 28th October 2022 at 14:00 p.m. CET.